Myelomaresearchnews.com

Dramatic gains in survival seen in myeloma since early 2000s But

WebThe first analysis included 3,336 patients diagnosed between 1995 and 2019. Results showed a significant increase in five-year RS over time: from 36.7% in the early …

Actived: 7 days ago

URL: https://myelomaresearchnews.com/news/dramatic-gains-in-survival-seen-in-myeloma-since-early-2000s-analysis/

FDA Approves Cilta-cel as Carvykti for Heavily Treated Myeloma

WebThe U.S. Food and Drug Administration (FDA) has approved the CAR T-cell therapy Carvykti (ciltacabtagene autoleucel) — formerly known as cilta-cel — for certain …

Category: Food Go Health

Myeloma Crowd Launches Online Tool to Help Patients Find …

Webby Patricia Inácio, PhD November 5, 2018. Myeloma Crowd has launched an online tool called HealthTree, aimed at helping patients with multiple myeloma find the …

Category: Health Go Health

HealthTree University Opens to Help Myeloma Patients Be Better

WebThe online portal HealthTree has opened a free and online patient resource connecting multiple myeloma experts from around the world with patients to help them …

Category: Health Go Health

New Nirogacestat Combos to Enter Myeloma Trials, SpringWorks …

WebThe collaboration with Pfizer aims to test nirogacestat plus PF‐06863135 in a Phase 1b/2 trial, while SpringWorks and Janssen will launch a Phase 1 trial investigating …

Category: Health Go Health

For Certain Multiple Myeloma Patients, Venclexta Safe and

WebA pre-planned safety analysis, however, revealed that the rate of death was significantly higher in the Venclexta group — 21% vs. 12% — which led the U.S. Food …

Category: Food Go Health

FDA Grants Myeloma ‘Off-the-shelf’ CAR T-cell Therapy Fast Track

WebThe T-cells in PBCAR269A are engineered to produce a man-made chimeric antigen receptor, or CAR, that helps them recognize and kill cells containing the B-cell …

Category: Health Go Health

Phase 3 trial of Venclexta for myeloma misses main goal But more

WebResults from the trial, dubbed CANOVA (NCT03539744), also showed that the Venclexta combo was associated with a significantly higher proportion of patients …

Category: Health Go Health

Elrexio now approved in Canada as recurring myeloma treatment

Webby Margarida Maia, PhD February 20, 2024. Health Canada has granted conditional approval to Pfizer’s Elrexfio (elranatamab-bcmm), expanding the list of …

Category: Health Go Health

Cilta-cel for Multiple Myeloma Named Breakthrough Therapy in …

WebCilta-cel refers to both LCAR-B38M, the name given to the therapy in China, and JNJ-4528, the name by which it is known outside of China.. The decision by the …

Category: Health Go Health

Study shows less hospital time for outpatient stem cell

Webby Steve Bryson, PhD July 11, 2023. Multiple myeloma patients undergoing a stem cell transplant in an outpatient setting spent about a week less in the hospital than those …

Category: Health Go Health

For Myeloma, ALL Patients, clonoSEQ Assay Now Covered by …

Webby José Lopes, PhD January 30, 2019. The clonoSEQ Assay — a test that detects cancer cells present in very small numbers in a patient’s bone marrow — will now be covered by …

Category: Cancer Go Health

Surge in Telehealth Brings Access, Convenience to Rare Disease

WebPart of that burden, estimated at nearly $1 trillion, is derived from traveling long distances to obtain medical care, causing patients to miss work or school for …

Category: Medical Go Health

Multiple Myeloma Patients Best Treated at Recognized Care …

WebData were collected using the University of North Carolina (UNC) Cancer Information and Population Health Resource (CIPHR), which includes information from …

Category: Cancer Go Health

Cancer Trial Data Will Be Shared in FDA's New Project Patient Voice

WebAstraZeneca, which is developing treatments for a variety of different cancers, is the first company to participate in the new venture.To start, the …

Category: Cancer Go Health

M-Power Project for African Americans Now Includes New York

Web“We are pleased to partner with the International Myeloma Foundation to launch M-Power New York, a program that follows the model used to help close the …

Category: Health Go Health

Prominent voices help spotlight myeloma risk in Black communities

WebThe national campaign, “That’s My Word,” will provide information and resources specifically for African Americans — who are at a twofold higher risk of …

Category: Health Go Health

More Studies Confirm Hefty Economic Burden of Rare Diseases

WebThe EveryLife study, covering 379 rare diseases affecting 15.5 million people in the U.S., put the total economic burden for 2019 at $966 billion. It was categorized into …

Category: Health Go Health

Patients Value Obamacare More Than General Public and Oppose …

WebInês Martins, PhD Inês holds a PhD in biomedical sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and …

Category: Medical Go Health